Evidence map›Paper›PMID 38505163›Full record

ArticleCurrent urology2024

A novel mortality risk score for emphysematous pyelonephritis: A multicenter study of the Global Research in the Emphysematous Pyelonephritis group.

Hegel Trujillo-Santamaría, José Iván Robles-Torres, Jeremy Yuen-Chun Teoh, Yiloren Tanidir, José Gadú Campos-Salcedo, Edgar Iván Bravo-Castro, Marcelo Langer Wroclawski, W S Yeoh, Santosh Kumar, Juan Eduardo Sanchez-Nuñez and 23 more

Abstract read
In one paragraph

Article in Current urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Hegel Trujillo-SantamaríaDepartment of Urology, Hospital Covadonga, Córdoba, México.
José Iván Robles-TorresDepartment of Urology, Hospital Universitario "Dr. José Eleuterio Gonzalez", Monterrey, México.
Jeremy Yuen-Chun TeohDepartment of Surgery, S.H. Ho Urology Centre, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.
Yiloren TanidirDepartment of Urology, Marmara University School of Medicine, Istanbul, Turkey.
José Gadú Campos-SalcedoDepartment of Urology, Hospital Central Militar, México City, México.
Edgar Iván Bravo-CastroDepartment of Urology, Hospital Central Militar, México City, México.
Marcelo Langer WroclawskiDepartment of Urology, Hospital Israelita Albert Einstein, BP-a Beneficência Portuguesa de São Paulo, Sao Paulo, Brazil.
W S YeohDepartment of Urology, University Surgical Cluster, National University Hospital, Singapore, Singapore.
Santosh KumarDepartment Urology, Christian Medical College, Vellore, Tamilnad, India.
Juan Eduardo Sanchez-NuñezDepartment Urology, Hospital General de México "Dr. Eduardo Liceaga", México City, México.
José Enrique Espinoza-AznarDepartment of Urology, Hospital Regional de Alta Especialidad de la Peninsula de Yucatán, Mérida, México.
Deepak RagooriDepartment Urology, Asian Institute of Nephrology and Urology, Hyderabad, India.
Saeed Bin HamriDepartment Urology, King Abdulaziz National Guard Hospital, Riyadh, Saudi Arabia.
Ong Teng AikDivision of Urology, Department of Surgery, University of Malaya, Kuala Lumpur, Malaysia.
Cecil Paul Tarot-ChocoojDepartment of Urology, Central Military Hospital, Mexico City, Mexico.
Anil ShresthaNational Academy of Medical Sciences, Bir Hospital and B&B Hospital, Gwarko Lalitpur, Nepal.
Mohamed Amine LakmichiDepartment of Urology, University Hospital Mohammed the VI of Marrakesh, Marrakesh, Morocco.
Mateus Cosentino-BelloteDepartment of Urology, Federal University of Paraná, School of Medicine, Hospital das Clínicas, Curitiba, Brazil.
Luis Gabriel Vázquez-LavistaDepartment of Urology, Hospital Médica Sur, Mexico City, Mexico.
Boukary KabreDepartment of Urology, Hospital Yalgado Ouedraogo Ouagadouga, Kadiogo, Burkina Faso.
Ho Yee TiongDepartment of Urology, University Surgical Cluster, National University Hospital, Singapore, Singapore.
José Gustavo Arrambide-HerreraDepartment of Urology, Hospital Universitario "Dr. José Eleuterio Gonzalez", Monterrey, México.
Lauro Salvador Gómez-GuerraDepartment of Urology, Hospital Universitario "Dr. José Eleuterio Gonzalez", Monterrey, México.
Umut KutukogluDepartment of Urology, Marmara University School of Medicine, Istanbul, Turkey.
Joao Arthur Brunhara Alves-BarbosaDepartment of Urology, Hospital Das Clínicas da Universidade de São Paulo, Sao Paulo, Brazil.
Jorge JaspersenDepartment Urology, Hospital General de México "Dr. Eduardo Liceaga", México City, México.
Christian AcevedoDepartment Urology, Hospital General de México "Dr. Eduardo Liceaga", México City, México.
Francisco Virgen-GutiérrezDepartment Urology, Hospital General de México "Dr. Eduardo Liceaga", México City, México.
Sumit AgrawalDepartment of Urology, AIIMS, Bhubaneshwar, India.
Hugo Octaviano Duarte-SantosDepartment of Urology, Hospital Municipal Dr. Moysés Deutsch (M'Boi Mirim), Sao Paulo, Brazil.
Chai Chu AnnDivision of Urology, Department of Surgery, University of Malaya, Kuala Lumpur, Malaysia.
Daniele CastellaniDepartment of Urology, Azienda Ospedaliero-Universitaria Ospedali Riuniti di Ancona, Polytechnic University of Le Marche Region, Ancona, Italy.
Vineet GahuarDepartment of Minimally Invasive Urology, Ng Teng Fong General Hospital, Singapore, Singapore.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Emphysematous pyelonephritis (EPN) is a necrotizing infection of the kidney and the surrounding tissues associated with considerable mortality. We aimed to formulate a score that classifies the risk of mortality in patients with EPN at hospital admission. Materials and methods: Patients diagnosed with EPN between 2013 and 2020 were retrospectively included. Data from 15 centers (70%) were used to develop the scoring system, and data from 7 centers (30%) were used to validate it. Univariable and multivariable logistic regression analyses were performed to identify independent factors related to mortality. Receiver operating characteristic curve analysis was performed to construct the scoring system and calculate the risk of mortality. A standardized regression coefficient was used to quantify the discriminating power of each factor to convert the individual coefficients into points. The area under the curve was used to quantify the scoring system performance. An 8-point scoring system for the mortality risk was created (range, 0-7). Results: In total, 570 patients were included (400 in the test group and 170 in the validation group). Independent predictors of mortality in the multivariable logistic regression were included in the scoring system: quick Sepsis-related Organ Failure Assessment score ≥2 (2 points), anemia, paranephric gas extension, leukocyte count >22,000/μL, thrombocytopenia, and hyperglycemia (1 point each). The mortality rate was <5% for scores ≤3, 83.3% for scores 6, and 100% for scores 7. The area under the curve was 0.90 (95% confidence interval, 0.84-0.95) for test and 0.91 (95% confidence interval, 0.84-0.97) for the validation group. Conclusions: Our score predicts the risk of mortality in patients with EPN at presentation and may help clinicians identify patients at a higher risk of death.

Indexed as

Emphysematous pyelonephritisMortalityPrognosis

Identifiers

PMID38505163
PMCPMC10946659

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.